Details of the Drug

General Information of Drug (ID: DMEMKIS)

Drug Name
ISIS 2503
Drug Type
Antisense drug
Sequence
TCCGTCATCGCTCCTCAGGG
Cross-matching ID
DrugBank ID
DB16181
TTD ID
D01XDN

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
H-ras messenger RNA (HRAS mRNA) TT28ZON RASH_HUMAN Not Available [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer. Clin Cancer Res. 2003 Jan;9(1):115-23.